.jpg)
The Case for Synthetic DNA in Modern Therapeutic Development
Kate Broderick talks with Cell and Gene about what changes when the starting material is made rather than grown.
Topics
Free Video
The Case for Synthetic DNA in Modern Therapeutic Development
Kate Broderick talks with Cell and Gene about what changes when the starting material is made rather than grown.
Watch the conversationLoading resources…
The blog posts couldn’t be loaded
This page reads posts from blog.artisbiosolutions.com, which only works when the page itself is published on that same domain (for example blog.artisbiosolutions.com/resources). Check the page’s domain in its settings.
Artis Insights
News
Publications, Webinars & More
Free Resources
.png)
Pure Synthetic oDNA for mRNA Therapies
Head-to-head IVT data on synthetic oDNA vs linearized plasmid DNA, plus a CEPI-funded Afrigen vaccine case study.
How to Choose the Right CDMO: A Complete Guide for Advanced Therapy Programs
A 58-page, five-part framework for evaluating CDMO partners, with an evaluation scorecard and the questions a capability deck never answers.
No resources match
Try a shorter search term, or clear the filters to see everything.